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Abstract
Background:  Indigenous Australians experience disproportionately high prevalence of, and
morbidity and mortality from diabetes. There is an urgent need to understand how Indigenous
primary care systems are organised to deliver diabetes services to those most in need, to monitor
the quality of diabetes care received by Indigenous people, and to improve systems for better
diabetes care.
Methods: The intervention featured two annual cycles of assessment, feedback workshops, action
planning, and implementation of system changes in 12 Indigenous community health centres.
Assessment included a structured review of health service systems and audit of clinical records.
Main process of care measures included adherence to guideline-scheduled services and medication
adjustment. Main patient outcome measures were HbA1c, blood pressure and total cholesterol
levels.
Results: There was good engagement of health centre staff, with significant improvements in
system development over the study period. Adherence to guideline-scheduled processes
improved, including increases in 6 monthly testing of HbA1c from 41% to 74% (Risk ratio 1.93, 95%
CI 1.71–2.10), 3 monthly checking of blood pressure from 63% to 76% (1.27, 1.13–1.37), annual
testing of total cholesterol from 56% to 74% (1.36, 1.20–1.49), biennial eye checking by a
ophthalmologist from 34% to 54% (1.68, 1.39–1.95), and 3 monthly feet checking from 20% to 58%
(3.01, 2.52–3.47). Medication adjustment rates following identification of elevated HbA1c and blood
pressure were low, increasing from 10% to 24%, and from 13% to 21% respectively at year 1 audit.
However, improvements in medication adjustment were not maintained at the year 2 follow-up.
Mean HbA1c value improved from 9.3 to 8.9% (mean difference -0.4%, 95% CI -0.7;-0.1), but there
was no improvement in blood pressure or cholesterol control.
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Conclusion: This quality improvement (QI) intervention has proved to be highly acceptable in the
Indigenous Australian primary care setting and has been associated with significant improvements
in systems and processes of care and some intermediate outcomes. However, improvements
appear to be limited by inadequate attention to abnormal clinical findings and medication
management. Greater improvement in intermediate outcomes may be achieved by specifically
addressing system barriers to therapy intensification through more effective engagement of medical
staff in QI activities and/or greater use of nurse-practitioners.
Background
Indigenous Australians experience disproportionately
high morbidity and mortality due to diabetes, substan-
tially more than can be explained simply by underlying
high diabetes prevalence among these populations. For
example, while the estimated prevalence of diabetes
among Indigenous adults (10% to 30%) was 2–4 times
higher than that of non-Indigenous Australians [1], hospi-
tal separation rates for diabetes were 10–15 times higher
[2], and the death rate associated with diabetes for 35–54
year old Indigenous people was 27–35 times higher [3]
when compared with non-Indigenous Australians. These
national statistics indicate that there is a need to improve
management of diabetes among Indigenous people at a
primary care system level to prevent or delay diabetes-
related complications.
In Australia, General Practice is the backbone of the main-
stream primary care system, and is supported by funding
from a national health insurance scheme (Medicare).
Most primary care is provided by self-employed general
practitioners (GPs), and services are reimbursed on a fee-
for-service basis [4]. GPs in primary care act as 'gatekeep-
ers', with access to specialist medical services being avail-
able only on their referral.
Primary care systems for Indigenous people are more
complex, with three main service provider sectors: the
Indigenous community controlled health service sector,
State and Territory government funded and/or operated
services, and general practitioners in private practice [5].
This complexity of Indigenous primary care systems is
particularly evident in the Northern Territory (NT). About
90% of Indigenous people in the NT live in 'discrete Indig-
enous communities' [6], and a majority of these people
access primary health care through community health
centres, operating under a variety of funding and govern-
ance models, rather than private general practice.
Many Indigenous community health centres are over-
whelmed by providing 'sickness care' for people who are
acutely unwell. Clinical consultations in Indigenous com-
munity health centres, compared with those in main-
stream general practice, tend to be more complex, with
more new patients and more problems managed [7].
These high demands for acute care services are a result of
high rates of illness in Indigenous communities [8]. Other
major challenges include inadequate staff numbers and
high staff turnover [8], geographic isolation, lack of resi-
dent (and infrequent visits by) general and specialist med-
ical staff [9] and inadequate funding [5].
These challenges add to the internationally recognised
inadequacy of acute care oriented systems for meeting the
needs of patients experiencing chronic problems [10].
Regardless of whether the problem is heart disease, diabe-
tes, or hypertension, effective management of chronic dis-
ease requires scheduled and regular patient visits to clinics
for monitoring disease control, detecting complications,
adjusting medications, and negotiating lifestyle changes.
The criticism that follow-up of chronically ill patients
tends to be sporadic, prevention underutilised, and the
patient's role in disease management overlooked in many
health systems [11] is generally applicable to Australian
Indigenous primary care.
While acute care services will always be necessary, Indige-
nous community health centres must at the same time
expand their systems to provide effective care for people
with chronic illness. In 1997, the health authorities in the
NT developed an integrated life course strategy to address
chronic disease (the Preventable Chronic Disease Strat-
egy), with a focus on maternal and child health, underly-
ing determinants of health, lifestyle modification, and
improved evidence based clinical practice for prevention,
early detection and management of chronic disease[12]. A
related development was the implementation in 1998 of
trials of "coordinated care" [13], which aimed to examine
the feasibility and impact of enhanced community con-
trol of funding and management of health services, and
the introduction of best practice clinical guidelines and
computerised information systems within two geographi-
cally defined regions in the NT. A more widely imple-
mented initiative over recent years has aimed to improve
paper-based recall systems in community health centres
[14]. However, little is known about the general nature
and use of systems in community health centres.
Against this background we developed a project to assess
the impact of a quality improvement (QI) intervention onBMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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primary care systems, processes and intermediate out-
comes of care for the management of diabetes in the
remote Indigenous community primary care setting. This
paper describes the experience and outcomes of two cycles
of the QI intervention in 12 Aboriginal community health
centres in the Top End of the NT, with a focus on under-
standing system related factors which hinder or facilitate
improvements in outcomes of care.
Methods
Study location and selection of health centres
This study was conducted in the Top End of the NT, an
area occupying 522,561 square kilometres with an esti-
mated resident population of 153,687 in 2003 [15].
Indigenous people comprise approximately 30% of the
total population of the NT [15]. We purposively selected
12 health centres (Figure 1) from a total of 53 centres in
the Top End, to reflect the diversity (rather than to be pro-
portionally representative) of health centres in the region
in terms of governance models (Indigenous community
controlled, NT department of health funded/operated,
and Health Board managed), population sizes (<500 res-
idents, 500–999, and ≥1000), and remoteness (indicated
by distance to the regional urban centres). Compared to
all health centres in the Top End, health centres funded/
operated by the NT department of health were under-rep-
resented in the sample, and health centres with medium-
sized populations (500–999) were over represented.
However, the 12 centres had good representativeness on
remoteness distribution.
The quality improvement (QI) intervention
Our QI intervention was conducted during 2002–2005
and featured two annual cycles of assessment, feedback,
action planning and implementation:
Assessment
There were two distinct levels of assessment: first of health
centre systems using an adapted version of the Assessment
of Chronic Illness Care (ACIC) scale [16-18];. and second
of quality of diabetes care via a patient record audit.
1) Our modified version of the ACIC scale included rela-
tively detailed prompts relating to 34 items which were
grouped into 7 components: organisational influence (3
items), external linkages (4 items), self-management (4
items), clinical decision support (3 items), delivery sys-
tem design (9 items), clinical information systems (6
items), and integration (5 items). Compared with the
original ACIC scale, this adapted version included three
additional items (cultural competence, pathology man-
agement, and pharmacy management) in the delivery sys-
tem design component, to reflect specific features of
interest in NT centres. Staff (managers, doctors, nurses,
Aboriginal health workers) were encouraged to discuss
their perceptions using the prompts, and to score through
consensus the level of development on a 0 (not at all) to
11 (fully developed) point scale. The mean was calculated
from individual item scores to create a component score,
and the mean of the 7 component scores formed the over-
all system score for the community health centre. The
scale served both as a measurement tool and an interven-
tion tool, as the discussion of system components led to a
better understanding among staff of the quality of systems
and consideration of how systems could be improved.
2) Quality of diabetes care was assessed through audit of
a sample of clinical records in terms of processes of care
(including guideline-scheduled services, medical treat-
ments and medication adjustment) and intermediate
patient outcomes (HbA1c, blood pressure, total choles-
terol and ACR [Albumin Creatinine Ratio]). Our stand-
ardised audit form was based on previous research work
in this area [19] and included a list of 27 scheduled service
processes which local clinical guidelines recommend at
specified intervals for people with diabetes [20]. A service
was assessed as delivered if there was a record of delivery
within the appropriate period preceding the audit.
We recorded prescribed medications for patients at the
time of the audit. Dose information was collected for all
hypoglycaemic, antihypertensive (including ACE inhibi-
tor), lipid-lowering, and anti-platelet medicines.
We also assessed whether the adjustment of medication
prescription was made among patients with HbA1c
Distribution of 12 participating community health centres in  the Top End of the Northern Territory, Australia Figure 1
Distribution of 12 participating community health centres in 
the Top End of the Northern Territory, Australia.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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>8.0% and >7%, and with BP > 140/90 and 130/80
mmHg at any stage over the 12 months prior to the audit.
While the clinical guidelines for the study population at
the time of commencement of our study recommended
treatment goals of ≤7% for HbA1c and ≤130/80 for blood
pressure for individuals [20], we specified the two cut
points for both HbA1c control and BP control to be used
as indicators of quality of control. The medical regimes
were considered as adjusted if the dose of a medicine was
increased, an additional agent added, or a medicine sub-
stituted by another one.
Intermediate outcomes of diabetes care include four
measures: all recorded values of HbA1c, blood pressure,
total cholesterol and ACR in the 12 months prior to the
audit. Patients were classified as hypertensive if there was
a diagnosis of hypertension documented in medical
records or they had blood pressure values >140/90 mmHg
in three separate checks. Albuminuria was defined as hav-
ing a diagnosis of renal disease documented in medical
records or ACR > 3.4. Patients were classified as having
hyperlipidemia if there was a diagnosis of hyperlipidemia
documented in medical records or they had a total choles-
terol level >5.5 mmol/L.
Audit sample
Community members who met all of the following crite-
ria were included in the study population: 1) a definite
diagnosis of type 2 diabetes according to health centre
records; 2) identified as Aboriginal; 3) aged 16 years or
older; and 4) lived in the community for 6 months or
more during the previous 12 months. In the four commu-
nity health centres where more than 30 eligible people
were identified in each centre (the actual numbers were
42, 60, 76 and 155 respectively) a random sample of 30
records was drawn for audit. The randomisation was con-
ducted by numbering the list of eligible patients and using
a computer generated list of 30 random numbers to be
included in the sample. In the eight other centres there
were fewer than 30 eligible people identified in each, and
records of all eligible people were audited. Overall, the
records of 295 people with type 2 diabetes were included
in the clinical record audit at baseline, which accounted
for 57% of the eligible people with diabetes (N = 519).
This sampling approach was designed to provide an ade-
quate number of records to reflect the situation in each
health centre rather than a representative sample of the
population of people with diabetes.
Of 295 participants at baseline, out-migration and death
resulted in a loss-to-follow-up of 42 participants at the
year 1 audit (n = 253) (Figure 2). With a further loss-to-
follow-up of 17 people and moving back of 16 from pre-
viously out-migrated people, 252 participants remained
for the year 2 audit.
Reliability of audit data
At each health centre, 10% of the records audited at base-
line were selected randomly and audited again one to two
months later by the same auditor for the same calendar
period. Each health centre contributed 2 or 3 records, and
the total reliability audit sample comprised 27 records.
Intra-rater reliability for different types of audit items
measured by Kappa statistics (κ), ranged from good to
very good [21]: demographics (κ = 1.00), diabetes related
complications (0.78–1.00), medications (0.91–1.00),
and processes of care (0.74–1.00).
Orientation, feedback workshops and action planning
Early meetings with health centre staff and management
were used as an opportunity to discuss the concepts of QI
and the need to reorient services to address chronic illness
effectively. As the project progressed we increasingly
emphasised the value of identifying root causes of poor
performance and the value of enhancing service systems
rather than specific clinical services. Action planning
workshops were held with staff and management of each
health centre as part of each QI cycle to feed back systems
assessment and clinical audit findings, compare perform-
ance with de-identified findings from other participating
centres, to share lessons from the varied experience of
health centres and to facilitate the development of action
plans. Given their important and unique role, a learning
conference was held to engage Aboriginal Health Workers
and strengthen their understanding of the quality
improvement intervention.
Follow-up of participants over the study period Figure 2
Follow-up of participants over the study period.
295 diabetes patients
253 diabetes patients
39 out-migrated
3 died
Baseline audit:
Year 1 audit:
Year 2 audit:
13 out-migrated
4 died
16 moved back
252 diabetes patientsBMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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Implementation
Health centres carried out their action plans. Health cen-
tre staff were asked to document activities and initiatives
relating to the implementation of action plans. The
research team provided ongoing support to health centres
in relation to implementation, mainly through email and
telephone communications, and sometimes by site visits
when necessary.
Statistical analysis
Means and proportions were used to summarise normally
distributed continuous and binomial data respectively,
and 95% confidence intervals were calculated after adjust-
ment for clustering by health centre. For data of non-
Gaussian distribution, medians and interquartile ranges
were used.
Changes in levels of health centre system development
regarding chronic illness care (as represented by ACIC
scores) and in quality of diabetes care (including proc-
esses and intermediate outcomes) over the study period
were assessed by comparing the year 1 data (collected after
one-year exposure to the intervention) and year 2 data
(collected after 2-years-exposure), respectively, with the
baseline data. As ACIC scores ranged from 0 to 11 and
were measured at health centre level with a sample size of
12, it was difficult to determine whether the Gaussian
assumption was met. Therefore, a non-parametric
method, the Wilcoxon matched pairs signed rank sum
test, was used for comparisons [21].
Multilevel regression models were used to assess changes
in processes and intermediate outcomes of diabetes care.
Three-level regression models were constructed to accom-
modate the inherent dependency structure of the data in
the presence of both repeated observations from the same
individuals (level 2 unit) and clusters within the same
community health centre (level 3 unit) [22]. Two inde-
pendent time variables, X1  (X1  = 0 denotes baseline
period; X1 = 1 year 1) and X2 (X2 = 0 denotes baseline
period; X2 = 1 year 2), were entered into the regression
models separately, and their regression coefficients,
respectively, indicated the average magnitude of changes
in quality of care one year and two years after the interven-
tion.
Two types of three-level regression models were employed
according to the nature of dependent variables. First,
three-level logistic regression models were used for
dichotomous dependent variables, for example, process
variable 'HbA1c was tested in previous 6 month (yes/no)'
and intermediate outcome variable 'HbA1c level was less
than 7.0% (yes/no)'. Regression coefficients were trans-
formed into odds ratios using eβ, and odds ratios then
were converted into risk ratios by means of a published
formula [23]. Second, three-level linear regression models
were used for continuous dependent variables (eg values
of systolic blood pressure). These analyses were con-
ducted using Stata version 8.2 (Stata Corporation, College
Station, Tex, USA). The command "gllamm" [generalised
linear latent and mixed models] was used with the "fam-
ily" option as "binomial" and the "link" option as "logit"
for three-level logistic regressions. Three-level linear
regressions were conducted using Stata command
"gllamm" with the "family" option as "Gaussian" and the
"link" option as "identity".
The study was approved by the Human Research Ethics
Committee of the Northern Territory Department of
Health & Community Services and the Menzies School of
Health Research, and by its Indigenous health research
sub-committee.
Results
Characteristics of the study participants at baseline
The records of 295 people with type 2 diabetes were
audited at baseline (Table 1). The sample included fewer
men than women (39% vs 61% at baseline). At baseline
the median age of the participants was 48 years (range 16–
87), with a high prevalence of smoking (36%) and micro-
vascular complications (42%). Approximately one-half of
the participants also had hypertension. Seventy-seven per-
cent of participants had attended their community health
centres within the previous 3 months.
Change in health centre system development
Median ACIC component scores at the baseline ranged
from 2.5 to 5.4 (Table 2). Scores improved progressively
and significantly over the two year follow-up. During the
course of the study health centre staff reported imple-
menting a range of strategies and actions to improve
health centre systems and services (Table 3). The strategies
involved either increased resources or innovative activities
that promoted and improved interaction between health
care providers and patients. For example, most health cen-
tres included specific goals of chronic illness care in their
business plans, with some lobbying their governing bod-
ies to secure funds to support new positions for a nurse or
chronic illness coordinator. The majority of strategies
were carried out with the use of existing resources and by
introducing creative initiatives to proactively engage com-
munity residents in chronic illness care. For example, a
health centre, in conjunction with community organisa-
tions, ran community-based programs (i.e. 'No Drugs, No
Violence, No Alcohol') to promote healthy lifestyle, and
provided incentives to stimulate and reinforce behaviour
changes. Changes in delivery system design were charac-
terised by regular review of roles among primary care team
members, designated staff time for home visits, and pro-
viding transport to clients for clinic visits.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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Table 2: Changes in levels of system development over study period (Assessment of Chronic Illness Care scores, potential range 0–11)
System components Baseline Year 1 Year 2 Change (P value)* 
Year 1 – baseline
Change (P value)* 
Year 2 – baseline
Median (Interquartile Range)
Organisational influence 3.4 (2.5, 4.3) 5.2 (4.5,5.3) 6.1 (4.5, 6.7) +1.8 (0.002) +2.7 (0.003)
External linkages 4.8 (4.0, 5.6) 5.4 (4.6, 6.0) 6.5 (5.3, 7.8) +0.6 (0.089) +1.7 (0.002)
Self-management support 3.8 (3.0, 3.9) 5.3 (4.2. 5.8) 6.4 (4.9, 7.3) +1.5 (0.005) +2.6 (0.004)
Decision support 4.7 (4.0, 5.0) 5.8 (4.7, 6.3) 7.2 (5.8, 8.2) +1.1 (0.077) +2.5 (0.025)
Delivery system design 4.5 (3.6, 5.2) 5.9 (5.3, 6.7) 7.2 (5.8, 8.2) +1.4 (0.002) +2.7 (0.007)
Clinical Information systems 5.4 (4.6, 5.9) 5.9 (5.3, 7.3) 7.7 (6.1, 8.3) +0.5 (0.037) +2.3 (0.015)
Integration 2.5 (1.9, 3.5) 4.5 (3.5, 5.4) 5.1 (4.1, 6.5) +2.0 (0.002) +2.6 (0.004)
Overall (Total) 4.3 (3.4, 4.7) 5.6 (4.6, 6.0) 6.1 (5.6, 7.3) +1.3 (0.002) +1.8 (0.002)
* P values are for Wilcoxon matched pairs signed rank sum tests. Changes significant at 0.05 level are shown in bold.
Table 1: Characteristics of clinical record audit sample at baseline (N = 295)
Characteristic Number (%), mean ± SD or median (interquartile range)
Median age (range), years 48 (16–87)
Men 116 (39%)
Median duration of diabetes*, years 5.7 (2.6, 8.7)
Current smokers 107 (36%)
Diagnosis of hypertension in medical record 140 (47%)
Diagnosis of hyperlipidaemia in medical record 84 (28%)
Any microvascular complications† 124 (42%)
Any macrovascular complications‡ 57 (19%)
Medical comorbid conditions§
0 86 (29%)
1 81 (27%)
2 63 (21%)
3 43 (15%)
4+ 22 (8%)
Attended health centre in last 3 months 226 (77%)
Attended health centre in last 12 months 270 (92%)
Reasons for last attendance during prior 12 months
Chronic illness care 164 (61%)
Acute care 88 (33%)
Sexual health or immunisation 18 (6%)
* Exclude 85 patients (29% of the total sample) whose date of diagnosis of diabetes was not documented in medical record.
† Microvascular complications include any retinopathy, nephropathy, neuropathy, renal disease, foot ulcer or amputation noted in the medical 
record.
‡ Macrovascular complications include any coronary artery disease or stroke noted in the medical record.
§ Medical comorbid conditions include hypertension, hyperlipidaemia, or any micro and macrovascular complications mentioned above.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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Table 3: Examples of strategies and actions implemented by participating community health centres to improve services and systems
Organisational influence
▪ Dedicated new Medicare officer time to process Medicare claims
▪ Prepared for the Australian General Practice Accreditation Limited (AGPAL) accreditation
▪ Secured financial resources to fund a new nurse position
▪ Lobbied to recruit a program coordinator to coordinate chronic illness care
▪ Developed a business plan including specific chronic illness care goals
▪ Increased support from the regional Quality Improvement Coordinator to implement quality plans
▪ Increased efficiency in claiming for Medicare funded items, with funds then used to support operation and maintenance of the computerised 
information system
External linkages
▪ In conjunction with schools, Women's Centres, community stores or takeaways, ran chronic disease prevention programs
▪ Held regular meetings with new formed health advisory committee of Aboriginal elders, facilitating community input into health centre operation. 
The committee was also consulted to provide leadership and direction of community-based health activities
▪ Funded new community development positions with the health centre assisting with networking in the community and working on prevention
▪ Supported community-based initiatives, such as 'Water Aerobics'
▪ Assisted visiting nutritionist in organising the healthy lunch program in the community, and meal design and preparation for the Aged Care Centre
▪ Designated health centre time for community work on Friday am
▪ Organised an event titled "No Drug, No Violence, No Alcohol " in the community, and offered incentives, such as a return airfare to Darwin 
(donated by Qantas), to promote behaviour changes
▪ Ran a Diabetes Health Day in the community to improve clients' understanding of their conditions
▪ Supported the Nutrition Worker based at the community store to provide healthy foods
▪ Identified and established a list of outside services, names, and contact numbers to assist all staff to contact services and to help patients use them
Self-management support
▪ Designated chronic disease nurses to provide self-management support
▪ Implemented written care plans which contained patient goals agreed between clinicians and patients. These goals were reviewed during each visit
▪ Developed key local language concepts
▪ Arranged visiting mental health team (4 times/year) to assist with behaviour change interventions
▪ Helped setting up a Diabetes Action group in the community
▪ Designed oral guidelines and pictures to disseminate self-management knowledge and skills
▪ Enhanced smoking cessation services supported by pharmacy and availability of patches for nicotine replacement treatment
▪ Addressed concerns of patients and families through existing peer support groups at the Women's Centre in the community
▪ Provided diabetes patients with blood glucose self-monitoring materials
▪ Showed patients a food box (designed by a nutritionist) as an education tool to support individuals and families about what type of food is good 
for managing chronic disease
▪ Organised patient peer groups to share their stories about care, for example, buying a scrubbing brush to clean feet, rubbing feet with cream, 
wearing shoes, and buying good tucker from the store
▪ Supplied sharps containers for insulin dependent patients to safely dispose of needles
▪ Educated patients on general safe storage of medications
▪ Organised patient eduction delivered by the visiting Diabetes Educator from the Healthy Living NT
Decision support
▪ Provided training for primary care team by visiting specialists (eg physicians)
▪ Developed chronic disease flow sheet based on clinical guidelines (the CARPA)
Delivery system design
▪ Organised chronic disease days with presence of specialist providers
▪ Designated chronic disease nurses to implement planned visits and group visits, eg facilitating patients seeing multiple providers in a single visit
▪ Developed and implemented cross culture education and training programs for staff
▪ Held regular team meetings to revise and reinforce team roles
▪ Used registers to identify active and non-active participation of patients, analysed reasons for non-active participation, and took measures to 
improve
▪ When the doctor was visiting, Aboriginal health workers went out and talked to patients, and brought them into the health centre
▪ Put a sign up at the community shop for doctor's and physician's visits, and picked up people if necessary
▪ Arranged for patients to see specialists (eg ophthalmologists) in the regional centre, and transported them to their appointments
▪ Utilised interpreters provided by the Aboriginal Resource and Development Services
▪ Went out twice a day to give medications to patients in the community
▪ The health team met regularly every morning to do handover and assign responsibility for patient follow-up
▪ Commenced the use of case conferencing for patients with complex conditions and to assign responsibilities to PHC team members
▪ One afternoon a week was set aside to do home visits for patients with major chronic conditions, and documenting relevant information in the 
medical recordsBMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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Change in quality of diabetes care
Delivery of guideline-scheduled processes of diabetes care
increased progressively over the study period (Table 4).
One year after the intervention, 9 out of a total of 27 serv-
ice items showed statistically significant improvement,
and this increased to 23 services after two years. Notably,
finger prick or venous blood sugar level (BSL) test
dropped from 61% to 51%, corresponding to an increas-
ing use of HbA1c testing.
However, the proportion of patients prescribed insulin,
oral hypoglycaemic agents, ACE inhibitors for those with
albuminuria, aspirin for those with established CVD and
treatment for hypertension and hyperlipidemia (statins)
at year 2 was not significantly different to baseline (Table
5). There was an increase in prescription of aspirin for
those with CVD risk factors at both years 1 and 2.
Based on documentation in medical records, after identi-
fication of elevated HbA1c and BP, there was an increase
in numbers of elevated results reviewed by a doctor, and
consequently, an increase in medication adjustment rates
at the year 1 audit (Table 6). However, these improve-
ments were not maintained at the year 2 follow-up, with
a significant drop in reviewing elevated results and medi-
cation adjustment during the year 2 period, even below
the baseline level. Over the same intervals, the number of
doctors employed (FTE) decreased from 9.5 at baseline to
9.3 at year 1 to 5.3 at year 2.
The mean HbA1c improved significantly from 9.3% at the
baseline to 8.9% at the year 1 audit, and maintained a
mean of 8.9% at the year 2 audit (Table 7). The propor-
tion of people with acceptable glycaemic control (HbA1c
< 8.0%) and ideal glycaemic control (HbA1c < 7.0%)
increased from 37% (baseline) to 46% (year 2), and from
19% to 28%, respectively. However, blood pressure con-
trol, total cholesterol control and maintenance of renal
function (measured by ACR) largely remained unchanged
over the study period.
Discussion
The study health centres initiated and implemented a
number of system changes over the two completed QI
cycles, and these developments are reflected in improve-
ments in the ACIC scores for all components of health
centre systems. Over the same period there was an
improvement in quality of diabetes care as reflected in
adherence to guideline-scheduled processes of care, but
limited increases in attention to abnormal findings and
medication adjustment. There was an improvement in
HbA1c control, but not in BP control or cholesterol levels.
Our findings on systems improvement are very similar to
those found in the first of the "Breakthrough" series in the
US [24] despite their inclusion of hospitals and academic
centres in addition to community based services. Com-
pared with the baseline data of our study, the participating
organisations had higher ACIC scores for organisational
influence and self-management support, but similar
scores for the other four components [18,25]. Similar
improvements in processes of care and in HbA1c meas-
ures were also reported after one year of a QI intervention
in 19 community health centres serving predominantly
disadvantaged populations in the Midwest of the USA
[26]. However, the intensity of the monthly cycles in the
Midwest study was perceived by staff to be too burden-
some, and potentially unsustainable. Our findings suggest
quality improvement interventions featuring conven-
tional, annual QI cycles can be comparably effective in
achieving improvement in diabetes care and may be more
likely to be institutionalised.
Improvements in key process measures, including HbA1c
and BP monitoring, were generally greater than for other
interventions in similar settings in Australia [19,27].
Although diabetes patients in our study experienced mod-
erate improvement in HbA1c control, no significant
improvement was found in other important intermediate
outcomes, namely blood pressure and total cholesterol
control. Difficulties in improving patient outcomes have
been increasingly reported by studies focusing on diabetes
quality improvement interventions [28-30]. For example,
in a systematic review [28] assessing effectiveness of
organisational and professional interventions on quality
of diabetes care in primary care settings, Renders et al
identified 13 studies that reported effects on both proc-
esses and outcomes of diabetes care. However, only 7 of
▪ Appointed the Health Centre Coordinator as team leader to ensure roles and responsibilities in chronic illness care
Clinical information systems
▪ Implemented a new electronic system (based on File Maker Pro) for recording of services, follow-up and reminding
▪ Performed a complete history notes audit and reorganised all individual files
▪ Installed a new computerised clinical information system, providing functions such as medical record-keeping, intelligent recalls, and featured 
appointments
▪ Developed and utilised a spreadsheet system with a list of people for follow-ups of 3 monthly bloods and the doctor's follow-ups of any abnormal 
findings
▪ Linked the health centre information system ("Communicare") with the regional information system "HealthConnect" to realise transfer of 
information between settings and community health centres
Table 3: Examples of strategies and actions implemented by participating community health centres to improve services and systems BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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these studies demonstrated a favourable effect on patient
outcomes in addition to a positive effect on processes of
care. In a recently published randomised controlled trial
[30], O'Connor and colleagues reported implementation
of a seven-step quality improvement change process in
primary care medical practices. After the 2.5-year imple-
mentation period, the intervention failed to improve
HbA1c, blood pressure, and LDL levels among patients,
although most processes of care, including annual test
rates of HbA1c, blood pressure and LDL, were signifi-
cantly improved.
An increasing number of commentators have ascribed dif-
ficulties in improving patient outcomes to 'clinical inertia'
(defined as failure of health care providers to initiate or
intensify therapy when evidence-based treatment goals
are not achieved) [31-35] but there has been a lack of lon-
gitudinal data to support this contention. Our data shows
seriously inadequate medical review and medication
adjustment following abnormal clinical findings and
investigations (notably BP and HbA1c), with an inade-
quate improvement after feedback of these findings. For
example, medication adjustment rates following identifi-
Table 4: Changes in processes of diabetes care
Process items Scheduled 
interval 
(months)
Baseline (n = 295) Year 1 (n = 253) Year 2 (n = 252) Risk Ratios (95% 
CI)† Year 1 vs 
baseline
Risk Ratios (95% 
CI)† Year 2 vs 
baseline
% of patients receiving services (95%CI)
Basic measurement
Weight 3 47 (41, 53) 43 (37, 49) 61 (54, 67) 0.90 (0.72, 1.10) 1.34 (1.14, 1.52)
Height Any time 32 (27, 38) 48 (42, 55) 71 (65, 76) 1.61 (1.30, 1.91) 2.35 (2.08, 2.56)
BMI 12 16 (12, 21) 21 (16, 26) 46 (40, 53) 1.24 (0.84, 1.76) 3.09 (2.36, 3.82)
Waist circumference 3 23 (18, 28) 28 (23, 34) 54 (48, 60) 1.28 (0.92, 1.70) 2.42 (2.00, 2.82)
BP 3 63 (57, 69) 63 (56, 68) 76 (71, 82) 0.94 (0.76, 1.10) 1.27 (1.13, 1.37)
Eye check
Visual acuity 12 40 (35, 46) 42 (36, 48) 58 (52, 65) 1.06 (0.83, 1.31) 1.49 (1.26, 1.71)
Cataracts 12 28 (23, 34) 35 (29, 41) 24 (19, 30) 1.31 (0.97, 1.68) 0.80 (0.58, 1.08)
Fundi (dilated pupils) 12 34 (29, 40) 36 (30, 42) 30 (25, 37) 1.10 (0.83, 1.39) 0.90 (0.68, 1.15)
Ophthalmologist 
review
24 34 (29, 40) 41 (34, 47) 54 (48, 61) 1.28 (0.99, 1.57) 1.68 (1.39, 1.95)
Feet check
Check done 3 20 (16, 25) 24 (19, 29) 58 (51, 64) 1.23 (0.84, 1.72) 3.01 (2.52, 3.47)
Sensation 3 9 (6, 13) 12 (8, 16) 48 (41, 54) 1.49 (0.87, 2.46) 5.81 (4.43, 7.16)
Peripheral pulses 3 8 (5, 12) 13 (9, 17) 48 (42, 54) 1.79 (1.05, 2.92) 6.61 (5.00, 8.17)
Pressure areas 3 7 (5, 11) 11 (7, 16) 44 (38, 51) 1.78 (0.99, 3.06) 6.96 (5.10, 8.85)
Infections 3 8 (6, 12) 12 (8, 17) 27 (22, 33) 1.64 (0.95, 2.69) 3.56 (2.39, 5.03)
Laboratory 
investigations
BSL (finger prick or 
venous)
3 61 (55, 67) 51 (44, 57) 69 (63, 74) 0.76 (0.60, 0.92) 1.13 (0.97, 1.27)
HbA1c 6 41 (35, 47) 61 (55, 67) 74 (68, 80) 1.54 (1.31, 1.75) 1.93 (1.71, 2.10)
Total cholesterol 12 56 (50, 62) 70 (64, 76) 74 (68, 79) 1.29 (1.13, 1.42) 1.36 (1.20, 1.49)
Urine – Dipstix 3 20 (15, 25) 24 (19, 30) 48 (42, 55) 1.29 (0.93, 1.74) 2.66 (2.15, 3.16)
Creatinine 12 65 (59, 71) 68 (62, 74) 74 (69, 80) 1.03 (0.88, 1.16) 1.15 (1.02, 1.26)
ACR 12 54 (48, 59) 54 (47, 60) 61 (55, 67) 0.99 (0.80, 1.16) 1.15 (0.99, 1.31)
Counselling/advice
Diet 3 15 (11, 19) 23 (18, 29) 36 (30, 42) 1.73 (1.17, 2.45) 2.54 (1.90, 3.26)
Activity 3 13 (9, 17) 22 (17, 27) 37 (31, 43) 1.82 (1.21, 2.62) 2.97 (2.20, 3.83)
Smoking 3 10 (7, 14) 21 (16, 26) 30 (25, 37) 2.30 (1.50, 3.36) 3.21 (2.24, 4.37)
Alcohol 3 9 (6, 13) 21 (16, 27) 33 (27, 39) 2.59 (1.67, 3.82) 3.78 (2.64, 5.11)
Diabetes medications 3 10 (7, 14) 26 (21, 32) 36 (30, 42) 2.95 (1.94, 4.20) 3.65 (2.63, 4.82)
Immunisations
Influenza vaccination 12 54 (48, 59) 47 (41, 53) 83 (78, 87) 0.83 (0.65, 1.01) 1.63 (1.50, 1.72)
Pneumococcal 
vaccination
5 yrs 73 (68, 78) 72 (66, 77) 80 (74, 85) 0.91 (0.73, 1.06) 1.10 (0.99, 1.18)
† Calculated by using multilevel logistic regression models with adjustment for health centre clustering and repeated measurements within the same 
individuals, and by converting odds ratios into risk ratios using a published formula. Risk ratios significant at 0.05 level are shown in bold.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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cation of elevated HbA1c improved from 10% at baseline
to 24% at year 1, but dropped to 3% at year 2. Over the
same intervals, the number of doctors employed (FTE)
dropped by 44%. It is likely that a certain and stable level
of doctors working at health centres provides a basis for
improvement in medication adjustment. Conversely, a
serious shortage of doctors significantly impedes efforts
for improvement. While there were relatively high rates of
prescribing of ACE inhibitors, of aspirin and relatively
good control of BP, the findings confirm that failure to
intensify medical management is likely to be an impor-
tant factor in the limited improvement in patient interme-
diate outcomes. This highlights the importance for
medical staff to be effectively engaged in QI interventions
and for the potential of nurse-practitioners to adjust med-
ications according to protocols.
The experience of our quality improvement intervention
suggests that increasing medication adjustment for diabe-
tes patients in primary care systems can be challenging
and complex. For example, while most computerised
information systems used by participating heath centres
provided prompts to health care providers that a test (e.g.
HbA1c) was due, none of these systems could further clas-
sify that patient results were at evidence-based goals or
not, and no prompts were provided to providers regarding
how therapy could be intensified for patients to achieve
their clinical goals. However, if future diabetes quality
improvement interventions are expected to improve
patient outcomes, medication adjustment measurements
should be routinely included in the spectrum of quality of
care measures, and barriers to making medical regimen
changes in healthcare systems need to be carefully identi-
fied, and effective strategies for overcoming these barriers
need to be tested and implemented.
While we aimed to include a cross section of services in
terms of remoteness, population size and governance
arrangements, the requirements of the participatory
action process meant our selection of services was influ-
Table 6: Frequency of elevated HbA1c and blood pressure results followed by documentation of review by a doctor and medication 
change over the study period
Follow up Baseline Year 1 Year 2 Risk Ratios (95% CI)‡ 
Year 1 vs baseline
Risk Ratios (95% CI)‡ 
Year 2 vs baseline
HbA1c recorded in previous 12 months* 291 296 317
Elevated HbA1c† (%) 173 (59%) 179 (60%) 169 (53%) 1.02 (0.89, 1.16) 0.90 (0.78, 1.03)
Reviewed by a doctor (%) 45 (26%) 82 (46%) 4 (2%) 1.76 (1.31, 2.37) 0.09 (0.03, 0.25)
Medication adjusted (%) 18 (10%) 43 (24%) 5 (3%) 2.31 (1.39, 3.84) 0.28 (0.11, 0.75)
BP recorded in previous 12 months* 615 559 588
Elevated BP† (%) 145 (24%) 154 (28%) 151 (26%) 1.17 (0.96, 1.42) 1.09 (0.89, 1.33)
Reviewed by a doctor (%) 30 (21%) 62 (40%) 5 (3%) 1.95 (1.34, 2.82) 0.16 (0.06, 0.40)
Medication adjusted (%) 19 (13%) 33 (21%) 5 (3%) 1.64 (0.98, 2.74) 0.25 (0.10, 0.66)
* As multiple HbA1c and BP results might be documented in the medical record for each patient in previous 12 month period, we only collected, 
when available, the two most recent HbA1c results and the three most recent BP results for each audit interval.
† Elevated HbA1c was defined as HbA1c > 8.0%. Elevated BP was defined as BP > 140/90 mmHg.
‡ Risk ratios significant at 0.05 level are shown in bold.
Table 5: Changes in pharmacological treatment rates over the study period
Treatment Baseline Year 1 Year 2 Risk Ratios (95% CI)† 
Year 1 vs baseline
Risk Ratios (95% CI)† 
Year 2 vs baseline
Any insulin use 10% (29/295) 11% (29/253) 10% (24/252) 1.17 (0.96, 1.40) 0.97 (0.79, 1.19)
Oral hypoglycaemic agents only 69% (203/295) 72% (181/253) 71% (180/252) 1.05 (0.83, 1.21) 1.08 (0.92, 1.20)
Hypertension on treatment 78% (112/143) 89% (111/125) 75% (119/159) 1.16 (1.04, 1.22) 0.96 (0.79, 1.09)
Albuminuria on ACE inhibitor 85% (129/151) 85% (124/146) 72% (114/158) 1.02 (0.86, 1.11) 0.87 (0.69, 1.00)
Hyperlipidemia on statin 71% (99/140) 83% (128/154) 67% (98/146) 1.34 (1.18, 1.39) 0.93 (0.75, 1.09)
Coronary heart disease/stroke on aspirin 56% (32/57) 60% (30/50) 70% (30/43) 1.00 (0.46, 1.47) 1.30 (0.85, 1.59)
Aspirin use among diabetes patients 
without cardiovascular events but with 
one or more other cardiovascular risk 
factors*
31% (53/173) 55% (91/165) 55% (101/184) 2.90 (2.11, 3.15) 2.21 (1.67, 2.62)
* Other cardiovascular risks refer to hypertension, hyperlipidemia and smoking.
† Risk ratios significant at 0.05 level are shown in bold.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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enced to an extent by the likelihood of achieving active
participation. The extent to which the findings are gener-
alisable may therefore be limited. The high rate of adop-
tion of QI processes by many services in the region (at
least partly as a result of this study) has limited the value
of conducting a comparative analysis with a non-interven-
tion group. The lack of a comparison group in the analysis
presented here and the two year duration of our time
series study does not provide a high level of evidence
regarding causal relationships between the QI interven-
tion and process or outcome measures. While the reliabil-
ity of our process and outcome measures obtained
through the use of the audit tools has been shown to be
good to very good, the facilitated self-report approach to
use of the ACIC scale leaves some potential for bias in
assessment of system development. However, this is
expected to be less than for other projects which have not
used a facilitator to standardise reporting and where the
tool has fewer standardised prompts.
Encouraged by the experiences and impressive improve-
ment achieved by participating health centres, we are cur-
rently extending the project to other jurisdictions to
establish a national collaborative with a view to investi-
gating how the quality improvement intervention devel-
oped in this study can be introduced and supported as
routine practice in Australian Indigenous primary care set-
tings. The collaborative will include service providers
from a number of other states. In addition, the extension
project will also test whether these quality improvement
approaches can be applied to chronic conditions other
than diabetes, including hypertension, coronary heart dis-
ease, renal disease, and mental illness. With a longer term
follow-up over a larger number of health centres, it will
provide better evidence on the nature of the causal rela-
tionship between QI interventions and quality of care.
Conclusion
This QI intervention has proved to be highly acceptable in
the Indigenous Australian primary care setting and has
been associated with significant improvements in systems
and processes of care and some intermediate outcomes.
Improvements appear to be limited by clinical inertia
with inadequate attention to abnormal clinical findings
or the intensification of medication management. Greater
improvement in intermediate outcomes may be achieved
with more effective engagement of medical staff in QI
activities and greater use of nurse-practitioners. Sustaining
and continuing the improvements in care will require
ongoing organisational commitment to support health
Table 7: Changes in intermediate patient outcomes over the study period
Intermediate outcomes Baseline Year 1 Year 2 Mean differences or Risk 
Ratios (95% CI)† Year 1 
vs baseline
Mean differences or Risk 
Ratios (95% CI)† Year 2 
vs baseline
Mean or percentage (95% CI)
HbA1c
Mean HbA1c level (%) 9.3 (8.8, 9.8) 8.9 (8.3, 9.4) 8.9 (8.6, 9.3) -0.4 (-0.7, -0.1) -0.4 (-0.7, -0.1)
HbA1c < 8% 37 (28, 46) 40 (30, 50) 46 (40, 52) 1.18 (0.79, 1.61) 1.43 (1.03, 1.82)
HbA1c < 7% 19 (13, 24) 21 (13, 29) 28 (22, 34) 1.16 (0.58, 2.09) 1.74 (1.11, 2.50)
Blood pressure (mmHg)
Mean systolic BP 130 (127, 133) 131 (128, 135) 130 (126, 133) 2.3 (-0.6, 5.2) -0.2 (-3.2, 2.8)
Mean diastolic BP 79 (77, 82) 79 (77, 82) 79 (76, 81) 0.4 (-1.6, 2.3) -0.3 (-2.1, 1.4)
BP < 140/90 65 (58, 72) 59 (51, 67) 67 (61, 73) 0.84 (0.66, 1.02) 1.04 (0.90, 1.17)
BP < 130/80 33 (25, 41)) 33 (23, 43) 29 (22, 36) 0.97 (0.69, 1.29) 0.80 (0.57, 1.10)
Total cholesterol (mmol/L)
Mean total cholesterol level 4.9 (4.7, 5.1) 4.9 (4.6,5.2) 4.9 (4.6, 5.3) -0.01 (-0.2, 0.2) -0.06 (-0.3, 0.2)
Total cholesterol < 5.5 73 (66, 80) 73 (64, 82) 73 (63, 84) 1.00 (0.77, 1.17) 1.02 (0.82, 1.16)
Total cholesterol < 4.0 22 (16, 28) 24 (17, 31) 30 (19, 41) 1.22 (0.68, 1.97) 1.58 (0.95, 2.35)
ACR
Median ACR level * 18.0 (3.7, 63.9) 19.6 (3.5, 83.2) 18.7 (4.8, 67.2) P = 0.49 P = 0.32
ACR ≤ 3.4 21 (13, 29) 24 (13, 35) 18 (13, 23) 0.93 (0.42, 1.78) 0.76 (0.35, 1.46)
3.4 < ACR ≤ 34 41 (33, 49) 33 (24, 42) 43 (35, 51) 0.73 (0.43, 1.11) 1.05 (0.72, 1.40)
ACR > 34 38 (29, 47) 43 (30, 56) 39 (30, 48) 1.60 (0.92, 2.16) 1.13 (0.67, 1.63)
* Figures in this row are medians (interquartile ranges). P values indicate statistical significance based on Wilcoxon-Mann-Whitney test for non-
parametric group comparison.
† Calculated by using multilevel regression models with adjustment for health centre clustering and repeated measurements within the same 
individuals, and by converting odds ratios into risk ratios when appropriate using a published formula. While the data for duration of diabetes were 
not sufficiently complete to allow for adjustment in the analysis (29% of participants had no date of diabetes diagnosis documented in medical 
records), additional adjustment for age did not significantly change the results. Therefore, we presented the data with no adjustment for age and 
duration of diabetes in this table. Mean differences or risk ratios significant at 0.05 level are shown in bold.BMC Health Services Research 2007, 7:67 http://www.biomedcentral.com/1472-6963/7/67
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centre staff to actively engage in ongoing QI cycles, with
re-invigoration and refinement of successful strategies.
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